氨酸:探索其治疗潜力和肺部疾病中的分子机制
Jialian Lv1, Xinyue Song1, Zixin Luo1
1The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Frontiers in pharmacology
|February 27, 2025
概括
植物类黄胺 (Luteolin) 是一种植物类黄胺,对肺部疾病有前途,但面临着生物可用性挑战. 研究正在推进配方,以提高其在治疗COPD和喘等疾病中的有效性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 肺部医学 肺部医学
背景情况:
- 丁醇是一种植物衍生的黄胺,具有显著的抗癌,抗炎和神经保护性质.
- 它通过调节PI3K/Akt和MAPK等关键信号通路,在各种肺病模型中展示了治疗潜力.
- 由于水溶性差和口服生物可用性低,丁的临床使用受到阻碍.
研究的目的:
- 审查提高黄素可溶性和生物利用性的进展.
- 总结黄素对肺部疾病及其潜在机制的治疗作用.
- 为未来的研究提供关于黄素的药理应用的见解.
主要方法:
- 关于黄素的药理活性研究的文献综述.
- 分析研究的配方策略,以提高氨酸的溶解性和生物可用性.
- 检查涉及黄素对肺部疾病影响的分子机制.
主要成果:
- 氨酸有效地向肺部疾病中与炎症和氧化应激有关的途径.
- 提高黄素溶解度和生物可用性的策略对于其治疗效果至关重要.
- 在COPD,ALI/ARDS,肺纤维化,喘和肺癌的临床前模型中,素显示出有前途.
结论:
- 改善黄素的药物配方是克服生物可用性限制的关键.
- 氨酸对一系列肺部疾病具有显著的治疗潜力.
- 对配方和机制进行进一步的研究是必要的,以获得临床转化.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
230
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
230
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Drugs Used in Lower Respiratory Disorders: Overview
335
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
335
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Antiasthma Drugs: Methylxanthines
182
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
182


